Helixmith Maintains Current Management... Appoints Two New Directors from Minority Shareholders

[Asia Economy Reporter Jang Hyowon] Helixmith announced that as a result of holding an extraordinary general meeting of shareholders over two days starting from the 14th, the current board of directors and management will remain in place, while two inside directors proposed by the minority shareholder coalition will be added.

In particular, the company and the minority shareholder coalition stated that they have agreed to coexist for the company's development and enhancement of shareholder value. They explained that they have agreed to engage in mutual dialogue, cease defamation, and withdraw lawsuits and complaints.

At this extraordinary general meeting of shareholders, about 70% of shareholders attended, and agenda items such as dismissal of the current board, appointment of a new board, and amendments to the articles of incorporation were proposed. As a result, the existing management and board, including CEOs Kim Sunyoung and Yoo Seungshin, were maintained, and candidates Choi Donggyu and Kim Hunsik, proposed by the minority shareholder coalition, were newly appointed as directors.

The company stated that it will meet with the new directors in the near future to jointly explore ways to develop the company and enhance shareholder value.

The company plans to announce soon some adjustments to the roles and responsibilities of each director to improve management efficiency and transparency, maximize the success of Enzygnis, and promote responsible management, taking this extraordinary general meeting as an opportunity.

CEO Yoo Seungshin said, “I deeply thank the shareholders who thoughtfully considered the company's future at this extraordinary general meeting. We will humbly accept this result and do our best to improve the company’s systems and operations.” He added, “We will closely cooperate with the two newly appointed directors to enhance the value of the company and shareholders and make every effort to grow Helixmith into a globally outstanding bio company.”

This content was produced with the assistance of AI translation services.